Related Experiment Videos

Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells

N J Panaro1, N C Popescu, S R Harris

  • 1Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Basic Sciences, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

British Journal of Cancer
|September 2, 1999
PubMed

Insights

Flavone acetic acid (FAA) causes cell cycle arrest in mammary carcinoma cells. This anti-cancer effect may involve reactive oxygen species generation.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Flavone acetic acid (FAA) is a synthetic flavonoid with demonstrated anti-tumour properties in animal models.
  • FAA's clinical efficacy was limited, necessitating further investigation into its molecular mechanisms of action.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Flavone acetic acid's (FAA) anti-tumour activities.
  • To examine the effect of FAA on the cell cycle progression of mammary carcinoma cells.

Main Methods:

  • Cell cycle analysis of mammary carcinoma cells treated with FAA.
  • Measurement of P34cdc2 (cdc2) cyclin-dependent kinase activity.
  • Morphological and cytogenetic analysis to assess effects on mitosis and cytokinesis.
  • Evaluation of the impact of antioxidants and specific inhibitors on FAA-induced cell cycle effects.

Main Results:

  • FAA induced a G2/M cell cycle arrest in mammary carcinoma cells.
  • Increased P34cdc2 (cdc2) activity was observed concurrently with cell cycle arrest.
  • FAA exhibited a colcemid-like effect, causing mitotic block and C-metaphase accumulation.
  • The cell cycle effects of FAA were mitigated by antioxidants (ADPC, ascorbate) and a superoxide scavenger (Tiron), but not by nitric oxide synthase inhibitors.

Conclusions:

  • Flavone acetic acid (FAA) induces cell cycle arrest in mammary carcinoma cells.
  • The mechanism may involve the stimulation of acidic sphingomyelinase, leading to reactive oxygen species (ROS) generation.
  • FAA's anti-tumour effects are potentially mediated through ROS-dependent cell cycle disruption.

Related Concept Videos